Covid-19 and people with neuromuscular disorders: World Muscle Society position and advice

Dr. Maxwell S. Damian, PhD, collated the World Muscle Society (WMS) Covid-19 advice (28th March 2020) for neuromuscular patients, carers, general neurologists and non-specialist medical providers. This document is also intended to inform neuromuscular specialists particularly regarding frequently asked questions and basic service requirements.

The advice is endorsed by the Members of the Board of the WMS, colleagues from the Editorial Board of Neuromuscular Disorders, the official journal of the WMS, European Academy of Neurology (EAN) Scientific Panel Muscle & NMJ disorders, and our network’s Executive Committee.

Latest updates


The documents listed below are translations of the original advice which was published on 28th March 2020.

Further versions of the advice (and their translations) will be available of the World Muscle Society website as, and when, they are released.

Original Translations:


Arabic – Rasha el Sherif

Chinese (Traditional) – Wen-Chen Liang

Czech – Jana Haberlova

DutchPeter van den Berg

English – Maxwell S. Damian

French – Shahram Attarian

GermanBenedikt Schoser

HungarianRita Horvath

Indonesian – Luh Ari Indrawati

ItalianAntonio Toscano

JapaneseTsuyoshi Matsumura

KoreanJongmok Lee

Polish – Anna Kostera-Pruszczyk

Portuguesa – Terehsina Evangelista

Portugues (Brazil)Mariz Vainzof

Russian – Leyla Akhmeedeva

SpanishMontse Olive

TurkishHaluk Topaloglu


The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission

“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit